MedPath

Safety and Performance of Newly Developed 1-piece Ostomy Product Compared With SenSura

Not Applicable
Completed
Conditions
Ileostomy - Stoma
Interventions
Device: Test product
Device: SenSura
Registration Number
NCT01799239
Lead Sponsor
Coloplast A/S
Brief Summary

The aim of the current investigation is to evaluate the combination of an adhesive with a soft top film.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  1. Have given written informed consent
  2. Be at least 18 years of age and have full legal capacity
  3. Be able to handle the bags themselves
  4. Have an ileostomy with a diameter between 15 and 55 mm
  5. Have had their ileostomy for at least 3 months
  6. Currently use a 1-piece flat ostomy appliance with open bag
  7. Use minimum 1 product every second day, i.e. maximum 2 days wear time
  8. Be suitable for participation in the study and for using a standard adhesive, flat base plate
  9. Must be able and willing to use custom cut products
  10. Accept to test two 1-piece products within the study period
Exclusion Criteria
  1. Use irrigation during the study period (flush the intestines with water)
  2. Currently receiving or have within the past 2 months received chemotherapy or radiation therapy
  3. Currently receiving or have within the past month received systematic steroid or local treatment in the peristomal area
  4. Are pregnant or breastfeeding
  5. Participating in other interventional clinical investigations or have previously participated in this investigation
  6. Currently using a ostomy belt
  7. Currently using extended wear product
  8. Have a loop ileostomy
  9. Known hypersensitivity towards any of the test products
  10. Suffering from severe peristomal skin problems prior to participation in the investigation (assessed by the study nurse)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
First SenSura, Then Test productSenSuraThe subject in this arm first test SenSura which is CE-marked and commerical available. After cross-over the subject test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details.
First Test product; then SenSuraSenSuraThe subject in this arm first test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details. After cross-over the subject test SenSura which is CE-marked and commerical available.
First Test product; then SenSuraTest productThe subject in this arm first test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details. After cross-over the subject test SenSura which is CE-marked and commerical available.
First SenSura, Then Test productTest productThe subject in this arm first test SenSura which is CE-marked and commerical available. After cross-over the subject test the Test product The test product is a newly developed ostomy appliance with a new top film. Due to company confidentiality the product is not described in further details.
Primary Outcome Measures
NameTimeMethod
Leakage (Percentage of All Baseplates With Leakage)After each baseplate change over a period, of 7 days

leakage is measured using a 4-point leakage scale developed by Coloplast A/S. At every baseplate change the subjects had to look at the skin facing side of the baseplate and access which of the four scenarios described below provided an accurate description of the baseplate.

The subjects tick of one of the four possible answers:

1. No leakage

2. Starting to leak (leakage under the baseplate)

3. Leakage (seepage of faeces resulting in leakage on clothes)

4. Sudden leakage (the baseplate pops off resulting in sudden leakage under the baseplate and outside the baseplate)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Skövde Hospital

🇸🇪

Skövde, Sweden

© Copyright 2025. All Rights Reserved by MedPath